Cargando…
Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis
INTRODUCTION: DNA methylation-induced silencing of genes encoding tumor suppressors is common in many types of cancer, but little is known about how such epigenetic silencing can contribute to tumor metastasis. The PRKD1 gene encodes protein kinase D1 (PKD1), a serine/threonine kinase that is expres...
Autores principales: | Borges, Sahra, Döppler, Heike, Perez, Edith A, Andorfer, Cathy A, Sun, Zhifu, Anastasiadis, Panos Z, Thompson, E Aubrey, Geiger, Xochiquetzal J, Storz, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052945/ https://www.ncbi.nlm.nih.gov/pubmed/23971832 http://dx.doi.org/10.1186/bcr3460 |
Ejemplares similares
-
The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma
por: Döppler, Heike, et al.
Publicado: (2015) -
The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer
por: Döppler, Heike, et al.
Publicado: (2016) -
The phosphorylation status of PIP5K1C at serine 448 can be predictive for invasive ductal carcinoma of the breast
por: Durand, Nisha, et al.
Publicado: (2018) -
Deficiency of PRKD2 triggers hyperinsulinemia and metabolic disorders
por: Xiao, Yao, et al.
Publicado: (2018) -
Protein Kinase D Isoforms Differentially Modulate Cofilin-Driven Directed Cell Migration
por: Döppler, Heike, et al.
Publicado: (2014)